<Record>
<Term>Extensively Drug-Resistant Tuberculosis</Term>
<SemanticType>Disease or Syndrome</SemanticType>
<ParentTerm>Tuberculosis, Multidrug-Resistant</ParentTerm>
<ClassificationPath>Bacterial Infections and Mycoses/Bacterial Infections/Gram-Positive Bacterial Infections/Actinomycetales Infections/Mycobacterium Infections/Tuberculosis/Tuberculosis, Multidrug-Resistant/Extensively Drug-Resistant Tuberculosis</ClassificationPath>
<BroaderTerm>Tuberculosis, Multidrug-Resistant</BroaderTerm>
<BroaderTerm>Tuberculosis</BroaderTerm>
<BroaderTerm>Mycobacterium Infections</BroaderTerm>
<BroaderTerm>Bacterial Infections</BroaderTerm>
<BroaderTerm>Extensively Drug-Resistant Tuberculosis</BroaderTerm>
<BroaderTerm>Gram-Positive Bacterial Infections</BroaderTerm>
<BroaderTerm>Actinomycetales Infections</BroaderTerm>
<BroaderTerm>Bacterial Infections and Mycoses</BroaderTerm>
<Synonym>Extensively Drug-Resistant Tuberculosis</Synonym>
<Synonym>Extensively Drug Resistant Tuberculosis</Synonym>
<Synonym>Extensively Drug-Resistant Tuberculoses</Synonym>
<Synonym>XDR-TB</Synonym>
<Synonym>Extremely Drug-Resistant Tuberculosis</Synonym>
<Synonym>Extremely Drug Resistant Tuberculosis</Synonym>
<Synonym>Extremely Drug-Resistant Tuberculoses</Synonym>
<Description>Tuberculosis resistant to ISONIAZID and RIFAMPIN and at least three of the six main classes of second-line drugs (AMINOGLYCOSIDES; polypeptide agents; FLUOROQUINOLONES; THIOAMIDES; CYCLOSERINE; and PARA-AMINOSALICYLIC ACID) as defined by the CDC.</Description>
<Source>MeSH</Source>
</Record>
